varenicline has been researched along with Depression in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 22 (75.86) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Caldarone, BJ; Eaton, JB; Kozikowski, AP; Lukas, RJ; Yu, LF; Zhang, HK | 1 |
| Anthenelli, RM; Beneventi, D; Blalock, JA; Cinciripini, PM; Green, C; Karam-Hage, M; Kypriotakis, G; Lawrence, D; Minnix, J; Morris, C | 1 |
| Gilbert, E; Hussain, S; Le Foll, B; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H | 1 |
| Ashare, RL; Bauer, AM; Flitter, A; Gross, R; Leone, F; Lubitz, SF; Quinn, MH; Schnoll, R; Thompson, M | 1 |
| Caldwell, DM; Dalili, MN; Keeney, E; López-López, JA; Munafò, MR; Phillippo, DM; Stevenson, M; Thomas, KH; Welton, NJ | 1 |
| McKee, SA; Moore, K; Oberleitner, L; Picciotto, MR; Roberts, W; Verplaetse, TL | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Ebbert, JO; Frye, MA; Geske, JR; Lineberry, TW; Patten, CA; Prince, CA | 1 |
| Gibbons, RD; Mann, JJ | 1 |
| Davies, NM; Gunnell, D; Martin, RM; Metcalfe, C; Thomas, KH; Windmeijer, F | 1 |
| Kausch, O | 1 |
| Hooten, WM; Warner, DO | 1 |
| Ebbert, JO; Elrashidi, MY; Hong, AS; Schroeder, DR | 1 |
| Gunnell, D; Higgins, JP; Knipe, DW; Martin, RM; Thomas, KH | 1 |
| Kotz, D; Sheikh, A; Simpson, C; van Schayck, OC; Viechtbauer, W; West, R | 1 |
| Davies, NM; Martin, RM; Munafò, MR; Taylor, AE; Taylor, G; Thomas, KH; Windmeijer, F | 1 |
| Amiaz, R; Boules, S; Davis, JM; Guidotti, A; Jin, H; Lajtha, A; Li, C; Liu, Y; Maayan, L; Ren, J; Sershen, H; Si, TM; Smith, RC; Weiser, M; Youseff, M | 1 |
| Brunner, D; Eaton, JB; Fedolak, A; Gunosewoyo, H; Kozikowski, AP; Lukas, RJ; Onajole, OK; Yu, LF; Zhang, HK | 1 |
| D'Souza, G; Kim, D; McGregor, AL; Tingle, MD | 1 |
| McIntyre, RS | 1 |
| Coe, JW; Guanowsky, V; Mineur, YS; Picciotto, MR; Rollema, H; Seymour, PA; Shrikhande, A | 1 |
| Chapin, DS; Freeman, J; Guanowsky, V; Hajós, M; Hoffmann, WE; Horner, WE; Johnson, DE; Kozak, R; Majchrzak, MJ; McLean, S; Rollema, H; Seymour, PA; Williams, KE | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 1 |
| Pelle, AJ; Smolderen, KG | 1 |
| Chatterjee, A; Garza, D; Murphy, M; Riordan, HJ; Tseng, LJ | 1 |
| Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R | 1 |
| Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S | 1 |
| Bechara, A; McNutt, A; Tranel, D | 1 |
| Andreas, S; Chenot, JF; Diebold, R; Mann, K; Peachey, S | 1 |
3 review(s) available for varenicline and Depression
| Article | Year |
|---|---|
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
Topics: Alkaloids; Antidepressive Agents; Azetidines; Azocines; Depression; Humans; Ligands; Molecular Targeted Therapy; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Receptors, Nicotinic | 2014 |
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
Topics: Bupropion; Cost-Benefit Analysis; Depression; Drug Costs; Electronic Nicotine Delivery Systems; Humans; Markov Chains; Models, Economic; Monte Carlo Method; Network Meta-Analysis; Nicotinic Agonists; Quality-Adjusted Life Years; Recurrence; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline | 2021 |
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.
Topics: Aggression; Benzazepines; Depression; Humans; Mental Disorders; Quinoxalines; Risk Factors; Sleep Wake Disorders; Suicide; Suicide, Attempted; Tobacco Use Cessation Devices; Varenicline | 2015 |
9 trial(s) available for varenicline and Depression
| Article | Year |
|---|---|
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
Topics: Bupropion; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polyesters; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2022 |
Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms.
Topics: Bupropion; Depression; Humans; Nicotinic Agonists; Smokers; Varenicline | 2023 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
A feasibility study of varenicline for smoking cessation in bipolar patients with subsyndromal depression.
Topics: Adult; Benzazepines; Bipolar Disorder; Depression; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2013 |
Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial.
Topics: Adult; Analgesics, Opioid; Benzazepines; Chronic Pain; Depression; Feasibility Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Opioid-Related Disorders; Pain Measurement; Pilot Projects; Quinoxalines; Single-Blind Method; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2015 |
Depressive symptoms among patients receiving varenicline and bupropion for smoking cessation.
Topics: Adult; Bupropion; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
Topics: Adult; Antipsychotic Agents; Cognition; Cotinine; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Nicotinic Agonists; Psychological Tests; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Symptom Assessment; Tobacco Use Cessation Devices; Varenicline | 2016 |
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Topics: Adolescent; Adult; Aged; Aggression; Anxiety; Benzazepines; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Comorbidity; Depression; Female; Germany; Humans; Hypertension; Incidence; Lung Diseases, Obstructive; Male; Middle Aged; Nicotinic Agonists; Observation; Primary Health Care; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
17 other study(ies) available for varenicline and Depression
| Article | Year |
|---|---|
Correlates of varenicline adherence among smokers with HIV and its association with smoking cessation.
Topics: Adult; Aged; Anxiety; Correlation of Data; Depression; Female; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Smoking; Varenicline | 2020 |
Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms.
Topics: Adult; Alcohol Drinking; Alcoholism; Comorbidity; Craving; Depression; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Outcome Assessment, Health Care; Varenicline | 2017 |
Varenicline, smoking cessation, and neuropsychiatric adverse events.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Male; Mental Disorders; Nausea; Observational Studies as Topic; Psychomotor Agitation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Depression; England; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Treatment of depression in a former smoker with varenicline? A case report and discussion.
Topics: Benzazepines; Depression; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Varenicline | 2014 |
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.
Topics: Adult; Bupropion; Cardiovascular Diseases; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study.
Topics: Anxiety; Depression; Humans; Logistic Models; Multivariate Analysis; Nicotinic Agonists; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Smoking; Smoking Cessation; Socioeconomic Factors; Suicide; Tobacco Use Cessation Devices; Varenicline | 2015 |
Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists.
Topics: Animals; Behavior; Depression; Inhibitory Concentration 50; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Nicotinic Agonists; Receptors, Nicotinic; Swimming; Varenicline | 2016 |
Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice.
Topics: Animals; Anxiety; Cell Proliferation; Cognition Disorders; Corpus Striatum; Depression; Disease Models, Animal; Female; Hippocampus; Huntington Disease; Male; Maze Learning; Memory; Mice, Transgenic; Motor Activity; Movement Disorders; Neural Stem Cells; Neuroprotective Agents; Nicotinic Agonists; Varenicline | 2017 |
Varenicline and suicidality: a new era in medication safety surveillance.
Topics: Adverse Drug Reaction Reporting Systems; Benzazepines; Depression; Drug Labeling; Humans; Psychomotor Agitation; Quinoxalines; Smoking Cessation; Suicide; Suicide Prevention; Varenicline | 2008 |
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect.
Topics: Animals; Antidepressive Agents; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming; Varenicline | 2009 |
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
Topics: Affect; Alcohol Drinking; Animals; Attention; Benzazepines; Cerebral Cortex; Cognition; Depression; Drug Partial Agonism; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Nicotinic Agonists; Quinoxalines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Nicotinic; Recognition, Psychology; Reflex, Startle; Reward; Tobacco Use Disorder; Varenicline | 2009 |
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline | 2010 |
Letter by Smolderen and Pelle regarding article, "Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial".
Topics: Benzazepines; Cardiovascular Diseases; Depression; Humans; Nicotinic Agonists; Patient Selection; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2010 |
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Topics: Adult; Benzazepines; Catecholamines; Depression; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Suicidal behavior and depression in smoking cessation treatments.
Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline | 2011 |
Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.
Topics: Adult; Benzazepines; Brain Injury, Chronic; Depression; Female; Humans; Male; Middle Aged; MMPI; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2012 |